Suppr超能文献

肽酶抑制剂对大鼠缓激肽诱导的支气管收缩的影响。

Effects of peptidase inhibitors on bradykinin-induced bronchoconstriction in the rat.

作者信息

Schilero G J, Almenoff P, Cardozo C, Lesser M

机构信息

Department of Medicine, Mount Sinai School of Medicine, New York, NY.

出版信息

Peptides. 1994;15(8):1445-9. doi: 10.1016/0196-9781(94)90122-8.

Abstract

Objectives of this study were to determine if aerosolized bradykinin causes bronchoconstriction in anesthetized, mechanically ventilated rats, and if pretreatment with enalaprilat, an inhibitor of angiotensin-converting enzyme (ACE), or phosphoramidon, an inhibitor of endopeptidase 24.11 (EP 24.11), alters the response. We found that aerosolized bradykinin elicited a reproducible bronchoconstrictor response that was significantly amplified by pretreatment with aerosolized enalaprilat or phosphoramidon. Neither inhibitor alone affected airway tone or caused nonspecific airway hyperreactivity. These findings indicate that both ACE and EP 24.11 contribute to bradykinin degradation in rat airways.

摘要

本研究的目的是确定雾化缓激肽是否会在麻醉、机械通气的大鼠中引起支气管收缩,以及用血管紧张素转换酶(ACE)抑制剂依那普利拉或内肽酶24.11(EP 24.11)抑制剂磷酰胺预处理是否会改变这种反应。我们发现,雾化缓激肽引发了可重复的支气管收缩反应,雾化依那普利拉或磷酰胺预处理可显著增强该反应。单独使用这两种抑制剂均不影响气道张力或引起非特异性气道高反应性。这些发现表明,ACE和EP 24.11都有助于大鼠气道中缓激肽的降解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验